At the time of writing, Elevance Health Inc [ELV] stock is trading at $395.76, up 1.75%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ELV shares have gain 5.14% over the last week, with a monthly amount glided 3.11%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Elevance Health Inc [NYSE: ELV] stock has seen the most recent analyst activity on April 15, 2025, when Robert W. Baird downgraded its rating to a Neutral but kept the price target unchanged to $529 for it. Previously, Argus upgraded its rating to Buy on March 17, 2025, and kept the price target unchanged to $450. On January 22, 2025, downgrade downgraded it’s rating to Equal-Weight and revised its price target to $440 on the stock. Argus downgraded its rating to a Hold. BofA Securities downgraded its rating to a Neutral and reduced its price target to $530 on July 18, 2024. Morgan Stanley started tracking with a Overweight rating for this stock on June 24, 2024, and assigned it a price target of $643. In a note dated May 30, 2024, Robert W. Baird initiated an Outperform rating and provided a target price of $649 on this stock.
For the past year, the stock price of Elevance Health Inc fluctuated between $357.45 and $567.26. Currently, Wall Street analysts expect the stock to reach $482.5 within the next 12 months. Elevance Health Inc [NYSE: ELV] shares were valued at $395.76 at the most recent close of the market. An investor can expect a potential return of 21.92% based on the average ELV price forecast.
Analyzing the ELV fundamentals
According to Elevance Health Inc [NYSE:ELV], the company’s sales were 183.12B for trailing twelve months, which represents an 14.83% jump. Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at 0.04%, Pretax Profit Margin comes in at 0.04%, and Net Profit Margin reading is 0.03%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.14 and Total Capital is 0.1. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.71.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 388.82 points at the first support level, and at 381.87 for the second support level. However, for the 1st resistance point, the stock is sitting at 401.62, and for the 2nd resistance point, it is at 407.47.
Ratios To Look Out For
It is important to note that Elevance Health Inc [NYSE:ELV] has a current ratio of 1.43. Considering the valuation of this stock, the price to sales ratio is 0.49, the price to book ratio is 2.10 and price to earnings (TTM) ratio is 15.44.
Transactions by insiders
Recent insider trading involved Kaye Mark, EVP & CFO, that happened on Apr 24 ’25 when 4588.0 shares were sold. Officer, Kaye Mark completed a deal on Apr 24 ’25 to buy 4588.0 shares. Meanwhile, CAO & Controller Penczek Ronald W sold 443.0 shares on Mar 10 ’25.
